Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Maharasnadi decoction (also known as Maharasnadi Kwath or Maharasnadi Kashayam) is a traditional multi-component Ayurvedic and Sri Lankan herbal formulation. It is prepared from a complex blend of botanical ingredients, primarily featuring Rasna (*Pluchea lanceolata*), alongside other herbs such as Dhanvayasa (*Fagonia cretica*), Bala (*Sida cordifolia*), Eranda-Mula (*Ricinus communis*), Devadaru (*Cedrus deodara*), and Shati (*Hedychium spicatum*). The formulation is traditionally used to pacify Vata dosha and possesses potent analgesic, anti-inflammatory, and anti-rheumatic properties. It has been clinically evaluated, including in a randomized non-inferiority trial conducted by the University of Colombo's Institute of Indigenous Medicine, for the treatment of knee osteoarthritis (Janu Sandigatavata) and other musculoskeletal and neurological disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Maharasnadi decoction.